Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
SURMOUNT-5, the first head-to-head trial (published in NEJM, 2025), found tirzepatide produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks
DSIP 99,4%, ,
Available exclusively for licensed research and laboratory use
Body Composition & Metabolic Health Sexual Enhancement We offer personalized supplement plans with the goal of supporting various aspects of health, including metabolism and overall well-being
Your path to well-being is one we're committed to walking with you
US$ 20.30
US$ 20.71
US$ 21.88
US$ 22.80
US$ 23.99
